SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Delta & Pineland Co.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: glen who wrote (32)5/11/1998 4:38:00 PM
From: Harry Ehrlich  Read Replies (5) of 67
 
I know one trader that believes this is not over yet. He feels that Novartis or DuPont will try to block the move with a better offer. They are the remaining players.

There is speculation that DuPont may try to buy Monsanto, which would eliminate DuPont as a bidder. This leaves Novartis.

I spoke with someone at investor relations at Delta. They are extremely pleased with the deal and the board of directors has approved it. The main reason for accepting is based on the fact that DuPont and Novartis are not in to cotton. They are years away from getting into cotton. Monsanto has worked with Delta and is ready to get into cotton right away.

There is a clause in the deal that would allow Delta to walk away from Monsanto (with penalties) if a better offer was made. So there is the possibility that Novartis might offer a better deal.

I feel this is a speculative hope, at best. But it is possible and a reasonable amount of open interest in the May 45 calls seems to indicate that others think so as well. My own feeling is that all options at 45 and above will most likely expire worthless. More possible might be some upward movement in Monsanto's price, which would ease the pain somewhat for recent (high) buyers of DLP.

Harry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext